Описание деятельности
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Правление & Наблюдательный совет
| Исполнительный директор |
| Dr. Daniel Koller |
| Правление |
| Dr. Thomas von Planta, Laura Hamill, Dr. Pearl Huang, Prof. Dr. Mads Krogsgaard Thomsen, Camilla Soenderby |
| Наблюдательный совет |
| Dr. Clive Meanwell |
Данные компании
| Имя: |
BB Biotech AG |
| Адрес: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
| Телефон: |
+41-52-624-0845 |
| Факс: |
- |
| E-mail: |
info@bbbiotech.com
|
| Интернет: |
www.bbbiotech.com |
| Индустрия: |
Financial |
| Сектор: |
Specialty Finance |
| Подсектор: |
Diversified Financial |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
97.00% |
| Дата IPO: |
10.12.1997 |
Связи с инвесторами
| Имя: |
Dr. Silvia Siegfried-Schanz |
| IR телефон: |
+41-44-267-7266 |
| IR-факс: |
- |
| IR e-mail: |
ssc@bellevue.ch
|
